ATE113937T1 - Tetrahydroisochinoline und tetrahydrobenzazepine und verfahren zur herstellung. - Google Patents
Tetrahydroisochinoline und tetrahydrobenzazepine und verfahren zur herstellung.Info
- Publication number
- ATE113937T1 ATE113937T1 AT89105218T AT89105218T ATE113937T1 AT E113937 T1 ATE113937 T1 AT E113937T1 AT 89105218 T AT89105218 T AT 89105218T AT 89105218 T AT89105218 T AT 89105218T AT E113937 T1 ATE113937 T1 AT E113937T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- same
- neuronal death
- delayed neuronal
- tetrahydroisochinolines
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000003111 delayed effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 230000016273 neuron death Effects 0.000 abstract 2
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 208000010496 Heart Arrest Diseases 0.000 abstract 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- -1 bicyclic amine compound Chemical class 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000002461 excitatory amino acid Effects 0.000 abstract 1
- 239000003257 excitatory amino acid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888807922A GB8807922D0 (en) | 1988-04-05 | 1988-04-05 | Isoquinoline compound & process for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE113937T1 true ATE113937T1 (de) | 1994-11-15 |
Family
ID=10634575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89105218T ATE113937T1 (de) | 1988-04-05 | 1989-03-23 | Tetrahydroisochinoline und tetrahydrobenzazepine und verfahren zur herstellung. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5059608A (de) |
| EP (1) | EP0336228B1 (de) |
| JP (1) | JP2674199B2 (de) |
| KR (1) | KR890016013A (de) |
| CN (1) | CN1036758A (de) |
| AT (1) | ATE113937T1 (de) |
| AU (1) | AU624128B2 (de) |
| DE (1) | DE68919252T2 (de) |
| DK (1) | DK161889A (de) |
| FI (1) | FI891582A7 (de) |
| GB (1) | GB8807922D0 (de) |
| HU (1) | HU206681B (de) |
| IL (1) | IL89736A0 (de) |
| NO (1) | NO891390L (de) |
| PH (1) | PH26281A (de) |
| ZA (1) | ZA892230B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA882080B (en) * | 1987-03-27 | 1989-04-26 | Schering Corp | Substituted benzazepines,their preparation and pharmaceutical compositions containing them |
| US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| US5837808A (en) * | 1991-08-20 | 1998-11-17 | Baxter International Inc. | Analogs of hirudin |
| US5246943A (en) * | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
| US5236934A (en) * | 1992-08-26 | 1993-08-17 | E. I. Du Pont De Nemours And Company | 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders |
| US5360569A (en) * | 1993-11-12 | 1994-11-01 | Lever Brothers Company, Division Of Conopco, Inc. | Activation of bleach precursors with catalytic imine quaternary salts |
| CA2176227C (en) * | 1993-11-12 | 2006-08-15 | Stephen Alan Madison | Imine quaternary salts as bleach catalysts |
| US5360568A (en) * | 1993-11-12 | 1994-11-01 | Lever Brothers Company, Division Of Conopco, Inc. | Imine quaternary salts as bleach catalysts |
| DZ2446A1 (fr) * | 1997-03-18 | 2003-01-11 | Smithkline Beecham Plc | Nouveaux composés |
| EP1023269A4 (de) * | 1997-09-30 | 2001-06-27 | Molecular Design Int | Beta3-adrenoreceptor-agonisten, agonist-zubereitungen und verfahren zu ihrer verwendung |
| US6593341B2 (en) | 2001-03-29 | 2003-07-15 | Molecular Design International, Inc. | β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same |
| US6596734B1 (en) | 2002-10-11 | 2003-07-22 | Molecular Design International, Inc. | Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists |
| KR100812843B1 (ko) * | 2005-06-01 | 2008-03-11 | 한화석유화학 주식회사 | 3,4-디히드로이소퀴놀리늄 염 유도체 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR204327A1 (es) * | 1973-07-20 | 1975-12-22 | Fujisawa Pharmaceutical Co | Procedimiento para la preparacion de derivados de 1,2,3,4-tetrahidroisoquinolina |
| JPS5734275B2 (de) * | 1973-07-30 | 1982-07-22 | ||
| US3963725A (en) * | 1973-07-20 | 1976-06-15 | Fujisawa Pharmaceutical Co., Ltd. | 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof |
| US4755218A (en) * | 1985-12-31 | 1988-07-05 | Monsanto Company | Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes |
| GB8800397D0 (en) * | 1988-01-08 | 1988-02-10 | Sandoz Ltd | Improvements in/relating to organic compounds |
-
1988
- 1988-04-05 GB GB888807922A patent/GB8807922D0/en active Pending
-
1989
- 1989-03-23 DE DE68919252T patent/DE68919252T2/de not_active Expired - Fee Related
- 1989-03-23 US US07/327,813 patent/US5059608A/en not_active Expired - Fee Related
- 1989-03-23 ZA ZA892230A patent/ZA892230B/xx unknown
- 1989-03-23 AT AT89105218T patent/ATE113937T1/de not_active IP Right Cessation
- 1989-03-23 EP EP89105218A patent/EP0336228B1/de not_active Expired - Lifetime
- 1989-03-24 IL IL89736A patent/IL89736A0/xx unknown
- 1989-03-29 PH PH38390A patent/PH26281A/en unknown
- 1989-04-03 FI FI891582A patent/FI891582A7/fi not_active IP Right Cessation
- 1989-04-03 NO NO89891390A patent/NO891390L/no unknown
- 1989-04-04 DK DK161889A patent/DK161889A/da not_active Application Discontinuation
- 1989-04-04 AU AU32432/89A patent/AU624128B2/en not_active Ceased
- 1989-04-04 CN CN89102133A patent/CN1036758A/zh active Pending
- 1989-04-04 JP JP1085172A patent/JP2674199B2/ja not_active Expired - Fee Related
- 1989-04-04 KR KR1019890004528A patent/KR890016013A/ko not_active Withdrawn
- 1989-04-05 HU HU891646A patent/HU206681B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA892230B (en) | 1989-11-29 |
| GB8807922D0 (en) | 1988-05-05 |
| HU206681B (en) | 1992-12-28 |
| NO891390L (no) | 1989-10-06 |
| DE68919252D1 (de) | 1994-12-15 |
| DE68919252T2 (de) | 1995-03-23 |
| NO891390D0 (no) | 1989-04-03 |
| JP2674199B2 (ja) | 1997-11-12 |
| DK161889D0 (da) | 1989-04-04 |
| EP0336228B1 (de) | 1994-11-09 |
| CN1036758A (zh) | 1989-11-01 |
| IL89736A0 (en) | 1989-09-28 |
| AU3243289A (en) | 1989-10-12 |
| FI891582L (fi) | 1989-10-06 |
| AU624128B2 (en) | 1992-06-04 |
| FI891582A0 (fi) | 1989-04-03 |
| DK161889A (da) | 1989-10-06 |
| JPH01294664A (ja) | 1989-11-28 |
| FI891582A7 (fi) | 1989-10-06 |
| KR890016013A (ko) | 1989-11-27 |
| US5059608A (en) | 1991-10-22 |
| PH26281A (en) | 1992-04-10 |
| HUT50782A (en) | 1990-03-28 |
| EP0336228A1 (de) | 1989-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE113937T1 (de) | Tetrahydroisochinoline und tetrahydrobenzazepine und verfahren zur herstellung. | |
| RU94013439A (ru) | Гетероциклические соединения, способ их получения, фармацевтическая композиция и способ лечения | |
| BG86132A (bg) | Производни на пиридазинамин | |
| PT97638A (pt) | Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem | |
| BR9813279A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processo de tratar uma doença de um corpo vivo de animal incluindo um ser humano | |
| PT89110A (pt) | Processo de preparacao de derivados da quinazolina e de composicoes farmaceuticas que os contem | |
| UA40589C2 (uk) | Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація | |
| EP1327452A3 (de) | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und SS-Mimetika | |
| MX173630B (es) | Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene | |
| ES2164109T3 (es) | Derivados de n-(3-piperidinilcarbonil)-beta-alanina como antagonistas de paf. | |
| NO864443D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater. | |
| DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
| DE68917937D1 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung. | |
| DK0624569T3 (da) | MMDA-antagonister | |
| IT1276167B1 (it) | Imidazo(1,2-alfa)chinossalin-4-ammine attivi come antagonisti adenosinici,procedimento per la loro preparazione e loro composizioni | |
| IT8748404A0 (it) | O-alcanoil derivati dell'acido 3ammino-2-idrossipropansolfonico adattivita'anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico dell'epilessia | |
| ES2005042A6 (es) | Procedimiento de preparar derivados de aminoacidos que tienen actividad sobre el sistema nervioso central. | |
| MY104521A (en) | Treatment of depression. | |
| FI891155A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi | |
| HUP0203650A2 (hu) | Heterociklusos származékok, eljárás az előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| ATE45958T1 (de) | Peptide, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung. | |
| RADOMSKI et al. | Pharmacological studies on the causative agent of canine hysteria | |
| ATE201993T1 (de) | Verwendung von olanzapine zur herstellung eines arzneimittels zur behandlung der zerebralen fokalen ischämie | |
| TH7755A (th) | ฟลูออซิทีน แอนาลอก | |
| PT85429A (en) | Process for the preparation of pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |